Naloxone
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 3
Sponsors and Collaborators
Hospices Civils de Lyon
Mechanism of Action
Other
Mechanism Description
Reducing Postictal Central Respiratory Dysfunction
Populations Tested In
SUDEP Prevention
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link